NCT01885897 2020-08-12IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCTMasonic Cancer Center, University of MinnesotaPhase 1/2 Completed33 enrolled 15 charts